Zoetis logo

Zoetis

ZTS | NYSE
Chart Builder DCF Calculator
$84.39
+$0.57 (+0.68%)
At close: Nov 16, 2026, 4:00 PM ET
$84.83
+$0.44 (+0.53%)
After-hours: Nov 16, 2026, 7:13 PM ET
+0.68%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 14, 2026
63.6
Fundamentals Strong
Market Sentiment Neutral
Moat Wide
Sector Rank #105/1021 (Top 10%)

Key Statistics

Market Data

Market Cap $34.29B
1D Range
83.18 84.57
52W Range
69.10 131.10

Valuation (TTM)

PE 14.35
PB 10.38
EV/EBITDA 10.95

Valuation (NTM)

Forward PE 13.28
Forward PEG -29.27
Price Target $84.00
Loading financial charts...

Profile

Zoetis Inc. stands as a global leader in animal health, focusing on the research, development, manufacturing, and commercialization of veterinary pharmaceuticals, vaccines, and diagnostic tools. Its c...

Sector Healthcare
Employees 14,500
IPO Date Feb 1, 2013
Fiscal Year January - December

Latest News

Zoetis Inc. (ZTS) Presents at Jefferies Global Healthcare Conference 2026 Transcript

14 hours ago · seekingalpha.com

Zoetis Inc. (ZTS) Presents at Jefferies Global Healthcare Conference 2026 Transcript
Zoetis' Cytopoint Plus Gets USDA License for 75-Day Canine Itch Relief

4 days ago · zacks.com

Zoetis' Cytopoint Plus Gets USDA License for 75-Day Canine Itch Relief
Zoetis Receives USDA License for Cytopoint Plus™: The First and Only Long-Acting Monoclonal Antibody Providing 75 Days of Allergic Itch Relief in Dogs with Allergic Dermatitis

5 days ago · businesswire.com

Zoetis Receives USDA License for Cytopoint Plus™: The First and Only Long-Acting Monoclonal Antibody Providing 75 Days of Allergic Itch Relief in Dogs with Allergic Dermatitis
Zoetis to Participate in the Jefferies Global Healthcare Conference in London

6 days ago · businesswire.com

Zoetis to Participate in the Jefferies Global Healthcare Conference in London
ZTS Q3 Earnings Call Highlights Competitive Pressures and Outlook

8 days ago · zacks.com

ZTS Q3 Earnings Call Highlights Competitive Pressures and Outlook
What Zoetis (ZTS) Said on Its Q3 Earnings Call

8 days ago · marketbeat.com

What Zoetis (ZTS) Said on Its Q3 Earnings Call
Zoetis: Quality Company Trading Cheap

11 days ago · seekingalpha.com

Zoetis: Quality Company Trading Cheap
Zoetis Inc. (ZTS) Q3 2026 Earnings Call Transcript

11 days ago · seekingalpha.com

Zoetis Inc. (ZTS) Q3 2026 Earnings Call Transcript
Zoetis: 3 Key Takeaways for Long-Term Investors

11 days ago · fool.com

Zoetis: 3 Key Takeaways for Long-Term Investors
ZTS Q3 Earnings Top Estimates, 2026 Profit Outlook Improves, Stock Up

11 days ago · zacks.com

ZTS Q3 Earnings Top Estimates, 2026 Profit Outlook Improves, Stock Up

Earnings

Latest Earnings
Nov 5, 2026
EPS
$1.75
Beat +15.89%
REV
$2.39B
Beat +3.79%
Next Earnings
Feb 11, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
15
Consensus
Hold
Price Target
$84.00
Downside
-0.46%
Buy (7)
Hold (8)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.